BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12703323)

  • 1. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors.
    Gomes I; Filipovska J; Devi LA
    Methods Mol Med; 2003; 84():157-83. PubMed ID: 12703323
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of function of receptor-G-protein and receptor-RGS fusion proteins.
    Ward RJ; Milligan G
    Methods Mol Biol; 2004; 259():225-47. PubMed ID: 15250496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant opioid receptors. Structure-function relationship.
    Filipovska J; Gomes I; Xu W; Chen C; Liu-Chen LY; Devi LA
    Methods Mol Med; 2003; 84():185-203. PubMed ID: 12703324
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing opioid regulation of adenylyl cyclase activity in intact cells.
    Thakker DR; Ozsoy HZ; Standifer KM
    Methods Mol Med; 2003; 84():29-37. PubMed ID: 12703314
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutational analysis of the structure and function of opioid receptors.
    Law PY; Wong YH; Loh HH
    Biopolymers; 1999; 51(6):440-55. PubMed ID: 10797232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering and functional immobilization of opioid receptors.
    Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
    Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization of opioid receptors: generation of novel signaling units.
    Levac BA; O'Dowd BF; George SR
    Curr Opin Pharmacol; 2002 Feb; 2(1):76-81. PubMed ID: 11786312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioid receptors and GTP-binding proteins].
    Ueda H; Harada J; Nishimura K; Ishida K; Uno S; Satoh M
    Nihon Rinsho; 1990 May; 48(5):953-61. PubMed ID: 2165540
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.
    Herrick-Davis K; Grinde E; Mazurkiewicz JE
    Biochemistry; 2004 Nov; 43(44):13963-71. PubMed ID: 15518545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
    Morou E; Georgoussi Z
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
    Chen T; Li X; Yang Y; Erdene AG; Church RL
    Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors.
    Zhen Z; Bradel-Tretheway BG; Dewhurst S; Bidlack JM
    J Neurosci Methods; 2004 Jul; 136(2):133-9. PubMed ID: 15183265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy.
    McVey M; Ramsay D; Kellett E; Rees S; Wilson S; Pope AJ; Milligan G
    J Biol Chem; 2001 Apr; 276(17):14092-9. PubMed ID: 11278447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants for membrane trafficking and G protein selectivity of a mouse olfactory receptor.
    Katada S; Tanaka M; Touhara K
    J Neurochem; 2004 Sep; 90(6):1453-63. PubMed ID: 15341529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGS2 interacts with Gs and adenylyl cyclase in living cells.
    Roy AA; Baragli A; Bernstein LS; Hepler JR; Hébert TE; Chidiac P
    Cell Signal; 2006 Mar; 18(3):336-48. PubMed ID: 16095880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study.
    Toth PT; Ren D; Miller RJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):8-17. PubMed ID: 15014135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G proteins and opioid receptor-mediated signalling.
    Standifer KM; Pasternak GW
    Cell Signal; 1997; 9(3-4):237-48. PubMed ID: 9218123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.